Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to news |u:www.enterprize.cam.ac.uk.  Search for news |u:www.enterprise.cam.ac.uk instead.
71 - 80 of 174 search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Creative Cambridge Annual Conference 2022 – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/our-events/creative-cambridge/creative-cambridge-annual-conference-2022/
    26 Jan 2023: Library. He is a BBC New Generation Thinker and regularly contributes to BBC Radio 3. ... We hear from innovators bringing entrepreneurial approaches and new technologies to bear in creative fields from gaming to fashion.
  3. How we use your personal information - Experts & Mentors –…

    https://www.enterprise.cam.ac.uk/privacy-compliance/data-protection/privacy-experts-mentors/
    1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – Experts & Mentors. How we use your personal information – Experts & Mentors. This policy is intended to assist you in making an informed
  4. Fluidic Analytics secures £1.56 million to develop protein…

    https://www.enterprise.cam.ac.uk/news/fluidic-analytics-secures-1-56-million-to-develop-new-protein-characterisation-technology/
    Thumbnail for Fluidic Analytics secures £1.56 million to develop protein characterisation – Cambridge Enterprise 22 Feb 2023: Fluidic Analytics is an exciting example of the new generation of companies that can transform healthcare from being a data-poor industry to a data-rich industry,” said Vishal Gulati, DFJ
  5. Horizon Discovery, DefiniGEN collaborate on iPS-based cell lines –…

    https://www.enterprise.cam.ac.uk/news/horizon-discovery-definigen-announce-collaboration-to-develop-gene-engineered-ips-based-cell-lines/
    Thumbnail for Horizon Discovery, DefiniGEN collaborate on iPS-based cell lines – Cambridge Enterprise 22 Feb 2023: Dr Paul Morrill, President, Products Business, Horizon, said: “Genome editing is now being applied to the generation of iPS disease models, creating an entirely new suite of research tools, enabling customers ... We look forward to partnering with
  6. Cambridge spin-out Xampla adds sustainability leader as Chair; earns…

    https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-xampla-adds-sustainability-leader-as-chair-earns-b-corp-status/
    Thumbnail for Cambridge spin-out Xampla adds sustainability leader as Chair; earns B Corp status – Cambridge Enterprise 23 Feb 2023: business. Simon Hombersley, Xampla CEO. We couldn’t be more pleased by the news of Xampla’s continued success.
  7. CellCentric raises $26m to take first-in-class p300/CBP inhibitor…

    https://www.enterprise.cam.ac.uk/news/cellcentric-raises-26-million-to-take-first-in-class-p300cbp-inhibitor-into-the-clinic/
    Thumbnail for CellCentric raises $26m to take first-in-class p300/CBP inhibitor into the clinic – Cambridge Enterprise 22 Feb 2023: There are few genuine first-in-class new drug opportunities which have a large but specific patient population to treat. ... The new financing will fund development of CCS1477 in this indication up to Phase IIb clinical testing.
  8. University of Cambridge breaks its early stage investment record for…

    https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-the-fourth-consecutive-year/
    Thumbnail for University of Cambridge breaks its early stage investment record for the fourth consecutive year – Cambridge Enterprise 22 Feb 2023: As a result of increased deal flow this year, the Seed Funds team has added three new members. ... Additionally, an Entrepreneur-in-Residence programme has been launched to assist the development of new ventures.
  9. University of Cambridge breaks its early stage investment record for…

    https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-third-consecutive-year/
    Thumbnail for University of Cambridge breaks its early stage investment record for third consecutive year – Cambridge Enterprise 22 Feb 2023: This new funding follows another successful year highlighted by the exit of X01 Limited, the developer of ichorcumab, an anticoagulant antibody with the potential to save millions of lives that was ... The investment funds will move forward the progress
  10. Sphere Fluidics and partners win InnovateUK grant for world’s first…

    https://www.enterprise.cam.ac.uk/news/sphere-fluidics-partners-win-innovateuk-grant-develop-worlds-first-desktop-genome-editing-system/
    Thumbnail for Sphere Fluidics and partners win InnovateUK grant for world’s first desktop genome editing system – Cambridge Enterprise 23 Feb 2023: Dr Craig said: “Sphere Fluidics is entering an exciting phase of internationalisation and this grant project supports our strategy of extending Cyto-Mine to new emerging global markets, such as the
  11. Four leading UK universities come together to showcase industry-ready …

    https://www.enterprise.cam.ac.uk/news/four-leading-uk-universities-come-together-to-showcase-industry-ready-innovation-addressing-global-challenges/
    Thumbnail for Four leading UK universities come together to showcase industry-ready innovation addressing global challenges – Cambridge Enterprise 14 Sep 2023: It’s a great opportunity for attendees to meet directly with our inventors and to assess a wide range of new technologies in one place.

Refine your results

Format

Related searches for news |u:www.enterprise.cam.ac.uk

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.